财新传媒
1111111
财新通行证
登录
忘记密码?
其他登录方式:
全部 杂志 博客 视频 图片
搜索结果:4990条 按作者 | 按标题 | 按全部
报告:预计2040年全球乳腺癌新发病例超过300万例[健康]

必须尽快采取措施,改善检测与预防;虽然对乳腺癌的研究和治疗已有极大改善,但巨大的不平等现象仍然存在

2024-04-19
美国药师协会报323种药物短缺 数量创新高[健康]

美国持续出现的药品短缺主要为低利润仿制药,涉急救和化疗等一些必需品种,该国此前已经放宽了部分急缺药品的进口限制

2024-04-16
夜读精选:提供女仆跪式服务 浙江义乌多家电竞剧本店被罚[夜读精选]

推荐:禽流感首次在南极洲大规模传播;票房|高评分电影扎堆 《白日之下》香港金像奖夺三奖

2024-04-15
生物医药研发,新加坡何以异军突起[聚焦]

新加坡政府长期以来致力于打造生物医学科研生态系统,不仅带来了经济成果,而且促进了战略性商业伙伴关系的建立、人才的吸引和药物发现方面的创新突破

2024-04-15
一周天下|马英九首访北京、俄哈遇70年来最严重洪灾疏散超10万人[一周天下]

2024-04-13
夜读精选:退市规则再收紧 应退尽退、不预设数量[夜读精选]

推荐:马斯克即将访问印度 或将宣布在当地建设特斯拉工厂;中央财政补贴汽车以旧换新 节能车亦有政策红利;专栏|用什么买到教育:分数,还是钱?

2024-04-12
图集|美国前橄榄球明星辛普森去世 曾因杀妻案轰动一时[滚动新闻]

2024-04-12
是时候大胆扩充年轻医生队伍了[刘明]

近年各地“规培”的时间纷纷缩短,从先前“三年”时长减少到了“两年”,这意味着青年医生的比重增加,对整个行业而言是新的机遇

2024-04-08
锦欣生殖加码布局东南亚辅助生殖市场[健康]

锦欣生殖的收益主要来自中国以及美国两大市场,在此番投资印尼辅助生殖医疗集团Morula之前,其业务范围虽已辐射至东南亚,但占比很小

2024-04-03
Caixin Weekly | A Long Road to Fundraising in the Middle East[One Idea Lab 2023-无效]

  • Chinese venture capital (VC) and private equity (PE) firms are increasingly exploring the Middle East for fundraising opportunities due to challenges in raising U.S. dollar funds and exiting through overseas listings, with over 200 firms visiting the region in 2023 despite a general trend of unsuccessful fundraising efforts.
  • The Middle East, home to half of the world's top ten sovereign wealth funds with assets expected to reach $7.6 trillion by 2030, presents an attractive but challenging market for Chinese VC/PE firms. These firms face cautious investors influenced by losses in other investments like SoftBank's Vision Fund and cultural and financial differences that emphasize long-term relationships over quick deals.
  • Despite the difficulties, some Chinese firms have established permanent presences in Abu Dhabi, and Middle Eastern sovereign wealth funds are showing increased direct investment in China, focusing on sectors such as new energy vehicles and aiming for economic diversification away from oil dependency.

2024-03-29
英矽智能二次递表港交所 全年收入同比增70%[健康]

在过去半年来,英矽智能已接连完成两项大额对外授权合作,合同金额总额最高可达15亿美元

2024-03-28
阿斯利康CEO苏博科:激励创新 减少国际合作壁垒[会议特稿]

苏博科表示,如果国际合作方面有太多壁垒,比如在数据交换、人类遗传资源采样等方面,会延缓行业发展

2024-03-25
葛兰素史克CEO魏爱玛:期待成人免疫等领域加强创新与合作[会议特稿]

2023年,GSK与国内疫苗企业智飞生物就其重组带状疱疹疫苗达成代理合作,也与中国药企进行了多项大额许可协议交易

2024-03-25
告别五大过去式,货币政策应转向全面宽松[滕泰]

当前,如果继续以“防通胀”的“过去式”思维为由拒绝全面宽松的货币政策,就会丧失应对通缩的最佳时机,造成严重的经济负向循环,给宏观经济带来风险

2024-03-25
NMN 'Elixir of Youth' Posts Strong Sales Even as Its Anti-Aging Properties Remain Unclear[Caixin Weekly Sneak Peek]

  • NMN (Nicotinamide Mononucleotide) supplements, known for their anti-aging properties, have gained global popularity and seen a surge in demand in China. Despite the lack of clinical trials to prove their efficacy and safety, these supplements are marketed as enhancing sleep quality, energy levels, and overall well-being.
  • China has become the largest producer and consumer of NMN raw materials and products. However, NMN-based products are sold as health supplements rather than approved drugs or food additives in China, leading to unregulated use among consumers without medical prescriptions or recommendations.
  • The pursuit of anti-aging solutions is not new but has gained momentum with advancements in understanding aging mechanisms. Researchers are exploring various small molecule drugs beyond NMN, such as metformin and rapamycin, for their potential to delay aging and treat age-related diseases. Nonetheless, extending lifespan does not necessarily mean improving the quality of life, highlighting the importance of targeting aging itself rather than individual diseases associated with it.

2024-03-23
【周刊提前读】“不老药”热卖 抗衰老效果却依然混沌[特报]

【本文系数据通用户提前专享】现有候选“药物”都有待进一步验证,未来“神药”落地仍有重重阻碍

2024-03-23
最新财新周刊|揭开“不老药”面纱[民生]

现有候选“药物”都有待进一步验证,未来“神药”落地仍有重重阻碍

2024-03-23
英国王储王妃凯特介绍自身罹癌治疗情况 英首相呼吁公众尊重王室隐私[要闻]

“大家可以想象到,这需要时间。为了开始治疗,我需要先从大手术中恢复过来”。但最重要的是,凯特说,她和威廉王子需要时间,以适合的方式向他们三名年幼的子女──乔治、夏洛特和路易斯解释一切

2024-03-23
研究:“16+8”断食或令心血管疾病死亡风险飙升[健康]

一种最早由减肥人士提出的节食方案,或许并没有长期的健康收益

2024-03-21
1800名肺癌患者赠药缘何中止?[健康]

该项目启动至今两年多,免费发放了64912盒药品,按照现行市场价约5000元/盒计算,这部分药品所能产生的销售额约为3.2亿元,和沃瑞沙2023年全年销售额相当

2024-03-20
加载更多新闻
gotop3